To the Editor:
We share Marwitz’1 concerns regarding widespread misinformation about coronavirus disease 2019 (COVID-19) treatments. However, we do not agree with the statement that "Past examples of vitamin C and zinc, marketed for common cold symptoms, make extensive claims about treating and curing common colds, but the data do not fully support safety and efficacy of these agents.2, 3, 4 Ironically, these agents are being promoted as unsubstantiated treatments or preventives for COVID-19 today.2"
In our Cochrane review, we found that regular vitamin C supplementation of at least 0.2 g/d shortened the duration of viral respiratory tract infections in adults by 7.7% (P < 0.001) and in children by 14.2% (P < 0.001).4 Our review supports the safety and efficacy of vitamin C.4 We did not demonstrate an effect when vitamin C was administered as a treatment, but low doses, short treatment, and late treatment may explain negative findings.4 Vitamin C may also have an effect on COVID-19,5 and a recent randomized trial observed that vitamin C increased the recovery rate of outpatients infected with severe acute respiratory syndrome coronavirus 2 by 70%.6
Marwitz1 refers to a zinc review3; however, the review is flawed.7 There is strong evidence that appropriately composed zinc lozenges can shorten the duration of respiratory virus infections.8, 9, 10, 11 Unfortunately, many of the zinc lozenges on the U.S. market contain either doses of zinc which are too low or substances that bind zinc ions so tightly that they are ineffective.11
There is much misinformation about vitamin C and zinc in popular forums and also, unfortunately, in scientific forums4 , 6, 7 , 12, 13, 14, 15; however, the positive findings from randomized trials should not be ignored.
Footnotes
ORCID
Harri Hemilä: https://orcid.org/0000-0002-4710-307X
Elizabeth Chalker: https://orcid.org/0000-0003-1593-3770
References
- 1.Marwitz K.K. The pharmacist’s active role in combating COVID-19 medication misinformation. J Am Pharm Assoc (2003) 2021;61(2):e71–e74. doi: 10.1016/j.japh.2020.10.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Adams K.K., Baker W.L., Sobieraj D.M. Myth busters: dietary supplements and COVID-19. Ann Pharmacother. 2020;54(8):820–826. doi: 10.1177/1060028020928052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Science M., Johnstone J., Roth D.E., Guyatt G., Loeb M. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ. 2012;184(10):E551–E561. doi: 10.1503/cmaj.111990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hemilä H., Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980. doi: 10.1002/14651858.CD000980.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hemilä H., de Man A.M.E. Vitamin C and COVID-19. Front Med (Lausanne) 2020;7:559811. doi: 10.3389/fmed.2020.559811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hemilä H., Carr A., Chalker E. Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z randomized clinical trial. Front Immunol. 2021;12:674681. doi: 10.3389/fimmu.2021.674681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hemilä H. Zinc acetate lozenges may shorten common cold duration by up to 40% CMAJ eLetter. 2012;184(10) doi: 10.1586/ers.12.30. https://researchportal.helsinki.fi/en/publications/zinc-acetate-lozenges-may-shorten-common-cold-duration-by-up-to-4 Available at: Accessed June 8, 2021. [DOI] [PubMed] [Google Scholar]
- 8.Hemilä H., Chalker E. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis. BMC Fam Pract. 2015;16:24. doi: 10.1186/s12875-015-0237-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hemilä H., Fitzgerald J.T., Petrus E.J., Prasad A. Zinc acetate lozenges may improve the recovery rate of common cold patients: an individual patient data meta-analysis. Open Forum Infect Dis. 2017;4(2):ofx059. doi: 10.1093/ofid/ofx059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017;8(5) doi: 10.1177/2054270417694291. 2054270417694291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Eby G.A., 3rd Zinc lozenges as cure for the common cold--a review and hypothesis. Med Hypo. 2010;74(3):482–492. doi: 10.1016/j.mehy.2009.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hemilä H. Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition. 1996;12(11–12):804–809. doi: 10.1016/s0899-9007(96)00223-7. https://helda.helsinki.fi/handle/10138/225877 Available at: Accessed June 8, 2021. [DOI] [PubMed] [Google Scholar]
- 13.Hemilä H. Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results. J Clin Epidemiol. 1996;49(10):1079–1084. doi: 10.1016/0895-4356(96)00189-8. https://helda.helsinki.fi/handle/10250/8082 [discussion 1085–1087] Available at: Accessed June 8, 2021. [DOI] [PubMed] [Google Scholar]
- 14.Hemilä H., Chalker E. Meta-analysis on vitamin C and the common cold in children may be misleading. Eur J Clin Pharmacol. 2019;75(12):1747–1748. doi: 10.1007/s00228-019-02733-x. [DOI] [PubMed] [Google Scholar]
- 15.Hemilä H., Chalker E. Commentary: The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19. Front Immunol. 2021;12:659001. doi: 10.3389/fimmu.2021.659001. [DOI] [PMC free article] [PubMed] [Google Scholar]